ENTHD1 antibody (Biotin)

Catalog No. ABIN1402993

This Rabbit Polyclonal antibody specifically detects ENTHD1 in WB and IHC (p). It exhibits reactivity toward Human, Mouse and Rat.

Quick Overview for ENTHD1 antibody (Biotin) (ABIN1402993)

Target: ENTHD1 (ENTH Domain Containing 1 (ENTHD1))

Reactivity: Human, Mouse, Rat

Host: Rabbit

Clonality: Polyclonal

Conjugate: This ENTHD1 antibody is conjugated to Biotin

Application: Western Blotting (WB), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))

Product Details anti-ENTHD1 Antibody (Biotin)

Cross-Reactivity: Human, Mouse, Rat

Purification: Purified by Protein A.

Immunogen: KLH conjugated synthetic peptide derived from human ENTHD1/Epsin2B

Isotype: IgG

Application Details

Application Notes: WB 1:300-5000
IHC-P 1:200-400

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: 1 μg/μL

Buffer: Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.

Preservative: ProClin

Precaution of Use: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.

Storage: -20 °C

Storage Comment: Store at -20°C for 12 months.

Expiry Date: 12 months

Target Details for ENTHD1

Target: ENTHD1 (ENTH Domain Containing 1 (ENTHD1))

Alternative Name: Epsin2B

Background:

Synonyms: CACNA1I, ENTD1_HUMAN, ENTH domain containing 1, ENTH domain-containing protein 1, ENTHD1, Epsin 2B, Epsin-2B, Gm1242, Gm86.

Background: The ENTHD1 gene is conserved in chimpanzee, dog, cow, mouse and rat, and maps to human chromosome 22q13.1. Chromosome 22 contains over 500 genes and about 49 million bases. Being the second smallest human chromosome, 22 contains a surprising variety of interesting genes. Phelan-McDermid syndrome, Neurofibromatosis type 2 and autism are associated with chromosome 22. A schizophrenia susceptibility locus has been identified on chromosome 22 and studies show that 22q11 deletion symptoms include a high incidence of schizophrenia. Translocations between chromosomes 9 and 22 may lead to the formation of the Philadelphia Chromosome and the subsequent production of the novel fusion protein, BCR-Abl, a potent cell proliferation activator found in several types of leukemia.

Gene ID: 953